The Consultation
A full consultation will be required with a registered prescriber to rule out any contraindications. A cooling off period is offered in order for the client to go away and think about the procedure and potential outcomes and side effects so that they are fully informed prior to making any decisions. At Belle Derma Aesthetics patient safety is paramount; this includes the individual having full opportunity to make a fully informed and justified decision prior to giving consent to undergo any procedure.
Alternative treatment options will also be discussed such as; microcurrent facials, microdermabrasion, collagen induction therapy and chemical peels.
Treatment Areas
Areas available for treatment of wrinkle relaxing injections include the glabellar (vertical frown lines- between eyebrows) frontalis (horizontal forehead lines), crows feet (sides and beneath eyes) and the nasalis (bunny lines- when nose is scrunched)
Some lines may still be prevelant at rest despite the use of wrinkle relaxing injections and may require the additional use of Dermal Fillers.
More details of the use of Dermal Fillers can be found on the page titled Dermal Fillers.
Wrinkle relaxing injections temporarily prevent the release of acetycholine from sympathetic nerve terminals. In simple terms it causes temporary paralysis of the muscles which create your frown lines.
It is a Prescription only medicine and comes in a variety of trade names.
Wrinkle relaxing injections should be used by trained members of the medical profession only. At Belle Derma Aesthetics your treatment will be prescribed by a Doctor and administered by a trained Nurse.
Individuals with a known hypersensitivity to any component of the formulation.
Patients who have generalised disorders of muscle activity (e.g. myasthenia gravis).
Patients where aminoglycoside antibiotics or spectinomycin are already being used or are likely to be used.
Patients who have bleeding disorders of any type.
Pregnant or lactating women.
Not recommended by the manufacturer for use in individuals under 18 years of age.
Treatment interval should not be more frequent than every three months as this can increase the risk of antibody formation.
Bruising, swelling, irritation or bleeding at the site of injection, headache, and rarely eyelid ptosis or diplopia, and brow droop.
|
|